CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
We have now added a new section called the "Assay History List" to the "At A Gla...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...